Unichem Labs posted a bumper set of numbers for Q3FY16. Its net profit soared almost 10 times to Rs.20 crore and this was on the back of super topline. Its net sales for the quarter was up 15% (YoY) at Rs.306 crore.

Revenue from domestic formulations rose 19% while that from international formulations business came in 23% down. Revenue from API formulations, excluding captive consumption was actually down 25%. EBITDA for the quarter was up 4.25 times at Rs.34 crore.

Little wonder then that the stock price intra day rose 8% to Rs.245.90 and it remains around the same levels even now. Its 52-week high and low stands at Rs.334 and Rs.174 respectively.